🇺🇸 FDA
Pipeline program

certepetide

LSTA1-P06

Phase 2 small_molecule terminated

Quick answer

certepetide for Pancreas Cancer is a Phase 2 program (small_molecule) at LISATA THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
LISATA THERAPEUTICS, INC.
Indication
Pancreas Cancer
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials